Home/Filings/4/0001181431-15-002917
4//SEC Filing

Sagent Pharmaceuticals, Inc. 4

Accession 0001181431-15-002917

CIK 0001369786operating

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:41 PM ET

Size

4.5 KB

Accession

0001181431-15-002917

Insider Transaction Report

Form 4
Period: 2015-02-18
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2015-02-18$27.22/sh452$12,30324,961 total

Documents

1 file

Issuer

Sagent Pharmaceuticals, Inc.

CIK 0001369786

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001369786

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:41 PM ET
Size
4.5 KB